The science · 科学依据

It started with one paper in 2007.

Hydrogen had been breathed by divers since the 1940s and studied on and off for decades. Then a Japanese team showed it was doing something far more interesting than anyone expected — and the field opened.

Everything below is published work. We link the originals so you can check us.

The origin

Professor Shigeo Ohta, Nippon Medical School.

In 2007 Ohta’s group published in Nature Medicine that molecular hydrogen acts as a selective antioxidant: it neutralises the hydroxyl radical (·OH) and peroxynitrite (ONOO⁻) — the two species that actually drive DNA damage, lipid peroxidation and mitochondrial collapse — while leaving the milder reactive oxygen species your cells use for signalling intact.

That single distinction is why hydrogen behaves differently from every antioxidant that came before it, and why the research volume went from a trickle to a flood.

Source · Ohsawa I, Ishikawa M, Takahashi K, et al. (Ohta S, senior author). Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nature Medicine 13, 688–694 (2007).

%

H₂ used in the original inhalation experiments

Disease models studied since, per Ohta’s reviews

Daltons — the smallest molecule there is

Not all free radicals are enemies.

Your body makes reactive oxygen species on purpose — for signalling, for immune defence. Only two of them are unambiguously destructive. Those are the two hydrogen reacts with.

Species What it does in the body H₂ reacts?
H₂O₂
Hydrogen peroxide
Cell signalling, growth, differentiation Left alone
O₂⁻
Superoxide
Immune defence, signalling Left alone
ROO·
Peroxyl radical
Moderately damaging Largely left alone
RO·
Alkoxyl radical
Moderately damaging Largely left alone
HOCl
Hypochlorous acid
Immune defence against pathogens Left alone
·OH
Hydroxyl radical
The most destructive species in biology Neutralised
ONOO⁻
Peroxynitrite
Potent oxidant, many pathologies Reduced

Why selectivity is the whole point

A conventional antioxidant — vitamin C, vitamin E — clears reactive species indiscriminately, which is one proposed explanation for why high-dose antioxidant supplementation has repeatedly disappointed in large trials: it may suppress useful signalling along with the damage. Hydrogen’s narrow reactivity is not a limitation. It is the reason it can be taken daily without blunting normal physiology.

Bioavailability

Two daltons. Nothing else gets in like this.

Vitamin C is hydrophilic and stops at the membrane. Vitamin E is lipophilic and needs a carrier. Coenzyme Q10 is far too large to cross into the brain. Hydrogen is electrically neutral, non-polar, and the smallest molecule in the universe — it diffuses where nothing else can follow.

01 · Through the blood-brain barrier

One of very few antioxidant molecules that reaches the central nervous system directly, rather than acting only in the periphery.

02 · Into the mitochondria

Oxidative stress originates at the cell’s energy plant. Hydrogen reaches the source rather than mopping up downstream.

03 · Into the nucleus

Where DNA sits. Protection at this level is why much of the research interest centres on ageing and long-term cellular health.

04 · Everywhere else, quickly

Inhaled hydrogen diffuses systemically within minutes. It is not targeted to one organ, and it does not accumulate.

What is left afterwards

H₂ + 2·OH → 2H₂O

When hydrogen neutralises hydroxyl radicals, the product is water. There is no metabolite to process, no residue to accumulate, no burden on the liver or kidneys. This is the plainest reason the safety profile is what it is.

How that translates into operating safety →

From a diving gas to clinical consideration.

Six moments that moved hydrogen from curiosity to something health systems felt obliged to evaluate.

Diving

1943

Swedish engineer Arne Zetterström makes the first documented use of a hydrogen–oxygen breathing mix for deep diving, reaching 160 m. The first evidence humans tolerate hydrogen at sustained pressure.

Early research

1975

Dole, Wilson and Fife report regression of skin tumours in mice under hyperbaric hydrogen, published in Science. Suggestive, never followed up at scale, and worth knowing about precisely because it went quiet.

Foundation

2007

Ohta’s group publishes the selective-antioxidant mechanism in Nature Medicine. The modern field begins here.

Emergency medicine

2016

Japan’s Ministry of Health, Labour and Welfare lists hydrogen inhalation as Advanced Medical Care B for post-cardiac-arrest syndrome, following a first-in-human pilot study published in Circulation Journal.

National protocol

2020

China’s National Health Commission includes hydrogen–oxygen inhalation in the seventh edition COVID-19 treatment protocol. A multi-centre trial associated with Academician Zhong Nanshan reports improvement in dyspnoea and disease severity.

Accumulated evidence

Today

Research spans well over a hundred disease models, with clinical trials registered across Asia, Europe and North America. Most remain small. The direction is consistent; the certainty is not yet there.

The people doing the work.

Hydrogen research is a small field with identifiable authors. These are the names you will meet repeatedly if you read the literature yourself.

Prof. Shigeo Ohta

Japan · Nippon Medical School

Senior author of the 2007 Nature Medicine paper that established selective antioxidation — the acknowledged starting point of the modern field. Has since published extensively on mechanism and on the regulatory path for hydrogen therapy.

Published work →

Prof. Sun Xuejun 孙学军

China · Naval Medical University

Among the first in China to study hydrogen biology systematically. Author of the founding Chinese-language texts on the subject, including Hydrogen Molecular Biology (2013) and Hydrogen Gas Medicine (2020), with work cited several thousand times.

Published work →

Academician Zhong Nanshan 钟南山

China · Respiratory medicine

Led and publicly backed the multi-centre hydrogen–oxygen inhalation research during COVID-19, which preceded the therapy’s inclusion in China’s seventh-edition national treatment protocol.

Published work →

Prof. He Qianjun 何前军

China · SJTU Center of Hydrogen Science

Works on nanomaterial-controlled hydrogen release, published in Nature Communications and elsewhere — extending hydrogen from inhalation towards targeted delivery.

Published work →

Tyler W. LeBaron

United States · Molecular Hydrogen Institute

Founded one of the earliest non-profit hydrogen research bodies. Compiles the global literature, pushes for trial registration, and is among the more vocal critics of overstated marketing claims within the industry.

Published work →

Dole, Wilson & Fife

United States · 1975

The Science paper that first suggested a therapeutic role for hydrogen. Included here because the field then ignored it for thirty years — a useful reminder of how slowly this kind of evidence actually moves.

Published work →

These researchers are not affiliated with H₂Hub and have not endorsed us. We list them because their published work is the evidence base we rely on — and because you should be able to read it without going through us.

Delivery

How you take it changes what you get.

This is the single most common source of confusion — and of misleading marketing. A result from an inhalation study does not transfer to a bottle of hydrogen water, and vice versa. The dose, the duration and the tissue reached are all different.

Method Dose delivered Where it is studied Practicality
Inhalation Highest and most sustained Cardiac arrest, COVID-19, most clinical protocols Needs a device
Hydrogen-rich water Lower, and it degasses quickly Metabolic and exercise studies Easy, portable
Hydrogen saline (IV) Controlled, clinical only Animal and hospital research Not consumer
Baths and topical Localised, poorly characterised Thin literature Limited evidence

Our studio and home sessions use inhalation at 333 ml/min because that is where the clinical literature is concentrated. Hydrogen water is a reasonable complement, not a substitute.

Where the evidence is thin.

An honest map matters more than a long citation list. If you only read one section on this page, read this one.

Much of the literature is preclinical

A large share of published hydrogen studies are animal or cell-culture work. Promising mechanisms in mice do not automatically translate to outcomes in people, and the history of antioxidant research is full of exactly that failure.

Human trials are usually small

Many human studies run with dozens rather than hundreds of participants, over weeks rather than years. They are suggestive, not conclusive. Large, long, independently funded trials remain rare.

Delivery methods are not interchangeable

Inhalation, hydrogen-rich water and saline infusion deliver very different doses to different tissues. A finding from one should never be quoted as evidence for another — and frequently is.

Effect sizes vary widely between people

Some participants in published studies show clear changes; others show none. Nobody can currently predict which group you are in. This is why your first session is free rather than bundled into a package.

The 1975 result was never replicated at scale

Dole’s tumour-regression finding in Science sat unexamined for three decades. We include it in the timeline for honesty, not as evidence of anything about cancer. It is not a claim we make.

Read it, then try it.

The literature is public and we will point you to it. The session is free and takes an hour.

H₂Hub is a wellness studio, not a medical provider. Nothing on this page is a diagnosis, a treatment, or a promise of a clinical outcome, and it is not a substitute for advice from your doctor. Where we cite research, we cite it as research — published findings, not claims about what will happen to you.

The question that usually comes next: is it safe?

Hydrogen is flammable in a specific concentration range. We set out where that range actually sits, what these machines produce, and the shut-off systems involved — with the numbers, not reassurance.
Read the safety page →